Literature DB >> 25474284

[Recommendations for the use of faecal microbiota transplantation "stool transplantation": consensus of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society of Infectious Diseases and Tropical Medicine].

P K Kump1, R Krause2, C Steininger3, H P Gröchenig4, A Moschen5, C Madl6, G Novacek7, F Allerberger8, C Högenauer1.   

Abstract

The intestinal microbiota has a pivotal role in the maintenance of health of the human organism, especially in the defense against pathogenic microorganisms. Alterations in the microbiota, also termed dysbiosis, seem to be involved in the pathogenesis of a variety of intestinal and extraintestinal diseases. Fecal microbiota transplantation (FMT), also known as stool transplantation, is a therapeutic procedure aiming at restoring an altered intestinal microbiota by administration of stool microorganisms from a healthy donor into the intestinal tract of a patient. FMT is most commonly used for recurrent forms of Clostridium difficile infections (CDI). There are currently many cohort studies in a large number of patients and a randomized controlled trial showing a dramatic effect of FMT for this indication. Therefore FMT is recommended by international medical societies for the treatment of recurrent CDI with high scientific evidence. Other potential indications are the treatment of fulminant CDI or the treatment of inflammatory bowel diseases. In the practical utilization of FMT there are currently several open questions regarding the screening of stool donors, the processing of stool and the mode of FMT application. Different modes of FMT application have been described, the application into the colon has to be preferred due to less reported side effects than the application into the upper gastrointestinal tract. So far only very few side effects due to FMT have been reported, nevertheless the use and risks of FMT are currently intensely debated in the medical community. This consensus report of the Austrian society of gastroenterology and hepatology (ÖGGH) in cooperation with the Austrian society of infectious diseases and tropical medicine provides instructions for physicians who want to use FMT which are based on the current medical literature. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 25474284     DOI: 10.1055/s-0034-1385562

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  7 in total

Review 1.  Fecal Microbiota Transfer.

Authors:  Andreas Stallmach; Arndt Steube; Philip Grunert; Michael Hartmann; Lena M Biehl; Maria J G T Vehreschild
Journal:  Dtsch Arztebl Int       Date:  2020-01-17       Impact factor: 5.594

Review 2.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

Review 3.  [Fecal microbiota transplantation].

Authors:  C Lübbert; B Salzberger; J Mössner
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

Review 4.  Faecal microbiota transplantation: a regulatory hurdle?

Authors:  Frederick Verbeke; Yorick Janssens; Evelien Wynendaele; Bart De Spiegeleer
Journal:  BMC Gastroenterol       Date:  2017-11-28       Impact factor: 3.067

5.  European consensus conference on faecal microbiota transplantation in clinical practice.

Authors:  Giovanni Cammarota; Gianluca Ianiro; Herbert Tilg; Mirjana Rajilić-Stojanović; Patrizia Kump; Reetta Satokari; Harry Sokol; Perttu Arkkila; Cristina Pintus; Ailsa Hart; Jonathan Segal; Marina Aloi; Luca Masucci; Antonio Molinaro; Franco Scaldaferri; Giovanni Gasbarrini; Antonio Lopez-Sanroman; Alexander Link; Pieter de Groot; Willem M de Vos; Christoph Högenauer; Peter Malfertheiner; Eero Mattila; Tomica Milosavljević; Max Nieuwdorp; Maurizio Sanguinetti; Magnus Simren; Antonio Gasbarrini
Journal:  Gut       Date:  2017-01-13       Impact factor: 23.059

Review 6.  From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation.

Authors:  Carole Nicco; Armelle Paule; Peter Konturek; Marvin Edeas
Journal:  Diseases       Date:  2020-04-15

Review 7.  Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review.

Authors:  Simon D Goldenberg; Rahul Batra; Ian Beales; Jonathan Leith Digby-Bell; Peter Miles Irving; Lee Kellingray; Arjan Narbad; Ngozi Franslem-Elumogo
Journal:  Infect Dis Ther       Date:  2018-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.